Objective measurement of therapeutic response in breast cancer using tumour markers
- 1 October 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (4) , 757-763
- https://doi.org/10.1038/bjc.1991.394
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Assessment of four monoclonal antibodies as serum markers in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breastEuropean Journal of Cancer and Clinical Oncology, 1988
- Serum CA 15-3 assay in the diagnosis and follow-up of breast cancerBritish Journal of Cancer, 1988
- COMPARISON OF CA15-3 AND CARCINOEMBRYONIC ANTIGEN IN MONITORING THE CLINICAL COURSE OF PATIENTS WITH METASTATIC BREAST-CANCER1988
- Markers in breast cancer: Does CEA add to the detection by CA 15.3?Breast Cancer Research and Treatment, 1988
- Evaluation of MSA as a serum marker in breast cancer: A comparison with CEABritish Journal of Cancer, 1988
- SERUM LEVELS AND BIOCHEMICAL CHARACTERISTICS OF CANCER-ASSOCIATED ANTIGEN CA-549, A CIRCULATING BREAST-CANCER MARKER1987
- Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancerInternational Journal of Cancer, 1987
- Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.Journal of Clinical Oncology, 1986